Last reviewed · How we verify
NCT06859047: TECH
The Echodynamic Approach
trial in Echocardiography, Transthoracic in 200 participants. Currently enrolling.
31 December 2025
Quick facts
| Lead sponsor | IRCCS Ospedale San Raffaele |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 200 |
| Start date | 1 January 2023 |
| Primary completion | 31 December 2025 |
| Estimated completion | 31 December 2025 |
| Sites | 3 locations across Italy |
Conditions studied
- Echocardiography, Transthoracic — all drugs for Echocardiography, Transthoracic →
- Right-heart Hemodynamics — all drugs for Right-heart Hemodynamics →
Sponsor
IRCCS Ospedale San Raffaele — full company profile →
Who can join
18 and older, any sex, with Echocardiography, Transthoracic or Right-heart Hemodynamics. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this prospective observational study is to assess the accuracy of non-invasive hemodynamic parameter estimation via trans-thoracic echocardiography (TTE) compared to the invasive gold standard of right heart catheterization (RHC). This study will include patients who undergo both TTE and RHC on the same day, under the same hemodynamic conditions. The primary research question is: how does the echodynamic evaluation perform compared to right heart catheterization?
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06859047
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Echocardiography, Transthoracic
Currently open trials in the same condition.
- NCT05747404 — The FUnctional TricUspid REgurgitation by 3D EChocardiography Cooperative Study · recruiting
Other IRCCS Ospedale San Raffaele trials
Trials by the same sponsor.
- NCT07530107 — Observational, Retrospective, Single-center Study Aimed at Evaluating Long-term Outcomes Following Transvenous Lead Extr · not yet recruiting
- NCT07171905 — CAT-VHL Exploring the Role of Carbonic Anhydrase IX as Diagnostic and Theranostic Target in Von-Hippel Lindau Disease · Phase 2 · recruiting
- NCT07275099 — Quality of Life, Psychological Impact, and Care-related Challenges in Patients Affected by Von Hippel-Lindau Syndrome. · not yet recruiting
- NCT06896305 — Impact of Exclusion Diet in Addition to Anti-TNF Therapy in Crohn's Disease and Ulcerative Colitis: a Prospective, Rando · NA · recruiting
- NCT06667128 — Optimization of Heart Failure (HF) Medical Therapy After Transcatheter Valve Intervention (TVI) in Patients With Heart F · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06859047 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by IRCCS Ospedale San Raffaele
- Last refreshed: 18 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06859047.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing